Document is current
Any future updates will be listed below
-
Authors
Kjaer, Trille Kristina https://orcid.org/0000-0002-1917-4241
Grand, Mia Klinten
Levinsen, Anne Katrine Graudal https://orcid.org/0000-0003-0906-1873
Jakobsen, Erik
Borre, Michael https://orcid.org/0000-0002-1519-9185
Zachariae, Robert https://orcid.org/0000-0001-9076-3068
Christiansen, Peer
Laurberg, Søren
Christensen, Peter
Hölmich, Lisbet Rosenkrantz https://orcid.org/0000-0002-1983-5222
Brown, Peter de Nully https://orcid.org/0000-0002-6522-4086
Johansen, Christoffer https://orcid.org/0000-0002-4384-206X
K. Kjaer, Susanne
Oksbjerg Dalton, Susanne
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0052543, NNF18OC0052543, NNF18OC0052543)
Helsefonden (20-B-0434, 20-B-0434, 20-B-0434)
Kræftens Bekæmpelse (R269-A15811, R269-A15811, R269-A15811)
- License Information
-
More Information
Article History
Received: 31 October 2024
Revised: 2 September 2025
Accepted: 23 September 2025
First Online: 7 October 2025
Competing interests
: The authors declare no competing interests.
: All methods were performed in accordance with relevant guidelines and regulations. The study was approved by the National Board of Health Data (Region Zealand (REG-059-2021)) and registered in the Danish Cancer Society Research Database (2019-DCRC-0066). There was no contact with cohort members. According to Danish legislation, informed consent or ethical board review are not required in a register-based study with no human biological material included in the study.
